Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma

NCT05470283 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Tumor
Metastatic Melanoma
Melanoma

Interventions

DRUG: OBX-115
DRUG: Acetazolamide
DRUG: Cyclophosphamide
DRUG: Furosemide
DRUG: Mesna
DRUG: Fludarabine Phosphate

Sponsor

M.D. Anderson Cancer Center